1. Home
  2. MRNS vs OCG Comparison

MRNS vs OCG Comparison

Compare MRNS & OCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNS
  • OCG
  • Stock Information
  • Founded
  • MRNS 2003
  • OCG 2018
  • Country
  • MRNS United States
  • OCG Hong Kong
  • Employees
  • MRNS N/A
  • OCG N/A
  • Industry
  • MRNS Biotechnology: Pharmaceutical Preparations
  • OCG Other Consumer Services
  • Sector
  • MRNS Health Care
  • OCG Consumer Discretionary
  • Exchange
  • MRNS Nasdaq
  • OCG Nasdaq
  • Market Cap
  • MRNS 29.9M
  • OCG 25.1M
  • IPO Year
  • MRNS 2014
  • OCG 2020
  • Fundamental
  • Price
  • MRNS $0.54
  • OCG $1.18
  • Analyst Decision
  • MRNS Buy
  • OCG
  • Analyst Count
  • MRNS 12
  • OCG 0
  • Target Price
  • MRNS $4.28
  • OCG N/A
  • AVG Volume (30 Days)
  • MRNS 3.2M
  • OCG 20.8K
  • Earning Date
  • MRNS 03-04-2025
  • OCG 11-12-2024
  • Dividend Yield
  • MRNS N/A
  • OCG N/A
  • EPS Growth
  • MRNS N/A
  • OCG N/A
  • EPS
  • MRNS N/A
  • OCG N/A
  • Revenue
  • MRNS $31,466,000.00
  • OCG $1,227,855.00
  • Revenue This Year
  • MRNS $14.97
  • OCG N/A
  • Revenue Next Year
  • MRNS $57.65
  • OCG N/A
  • P/E Ratio
  • MRNS N/A
  • OCG N/A
  • Revenue Growth
  • MRNS 1.63
  • OCG N/A
  • 52 Week Low
  • MRNS $0.22
  • OCG $0.91
  • 52 Week High
  • MRNS $10.50
  • OCG $2.60
  • Technical
  • Relative Strength Index (RSI)
  • MRNS 70.29
  • OCG 44.84
  • Support Level
  • MRNS $0.54
  • OCG $1.15
  • Resistance Level
  • MRNS $0.56
  • OCG $1.33
  • Average True Range (ATR)
  • MRNS 0.02
  • OCG 0.09
  • MACD
  • MRNS 0.01
  • OCG 0.00
  • Stochastic Oscillator
  • MRNS 93.71
  • OCG 18.52

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

About OCG Oriental Culture Holding LTD

Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance service to customers in China and Hong Kong. It operates through one segment namely, e-commerce of artwork trading. It generates revenue through listing service fees, transaction fees, and other revenues collected from traders.

Share on Social Networks: